Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)

SHE:002370 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	338.82	618.72	743.85	720.47	757.62	821.11
Cash & Short-Term Investments	428.52	618.72	743.85	720.47	757.62	821.11
Cash Growth	-30.65%	-16.82%	3.25%	-4.90%	-7.73%	-9.06%
Accounts Receivable	160.92	155.05	111.68	111.8	115.65	85.24
Other Receivables	72.7	0.53	16.14	29.19	15.14	1.18
Receivables	233.62	155.58	127.82	140.99	130.79	86.42
Inventory	87.13	107.25	70.13	89.47	95.2	60.9
Other Current Assets	22.33	16.72	13.36	4.24	21.23	27.41
Total Current Assets	771.6	898.27	955.16	955.18	1,005	995.85
Property, Plant & Equipment	285.7	294.73	338.11	364.79	385.89	433.99
Long-Term Investments	89.62	38.01	38.49	37.75	40.96	58.27
Goodwill	14.51	-	-	-	-	-
Other Intangible Assets	55.08	44	54.2	59.21	57.22	51.57
Long-Term Deferred Tax Assets	0.09	-	-	-	0.25	-
Long-Term Deferred Charges	6.55	4.7	15.82	11.37	22.14	71.1
Other Long-Term Assets	-	-	-	1.08	12.56	-
Total Assets	1,223	1,280	1,402	1,429	1,524	1,611

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	62.9	103.97	45.77	51.8	89.83	53.93
Accrued Expenses	7.86	18.17	17.08	16.98	22.73	21.65
Short-Term Debt	7.1	-	30.06	50.06	50.06	-
Current Portion of Long-Term Debt	-	-	301.7	-	-	110.16
Current Portion of Leases	-	-	-	-	1.7	1.35
Current Income Taxes Payable	2.38	-	-	-	-	-
Current Unearned Revenue	4.08	14.75	2.23	7.96	14.47	2.77
Other Current Liabilities	10.98	15.36	19.6	35.01	43.58	24.3
Total Current Liabilities	95.3	152.24	416.44	161.8	222.38	214.15
Long-Term Debt	17.5	-	-	639.48	900.01	861.58
Long-Term Leases	0.58	-	-	-	-	1.34
Long-Term Unearned Revenue	2.36	3.21	4.36	5.56	6.83	15.16
Long-Term Deferred Tax Liabilities	5.8	3.98	3.86	3.61	3.55	5.94
Other Long-Term Liabilities	-	-	4.93	38.04	89.83	79.65
Total Liabilities	121.54	159.43	429.59	848.5	1,223	1,178

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	745.67	745.67	728.59	609.17	536.69	536.62
Additional Paid-In Capital	2,005	2,005	1,907	1,594	1,310	1,309
Retained Earnings	-1,645	-1,630	-1,727	-1,761	-1,749	-1,616
Comprehensive Income & Other	-	-	63.35	138.8	203.57	203.8
Total Common Equity	1,086	1,120	972.18	580.87	301.27	432.96
Minority Interest	15.55	-	-	-	-	-
Shareholders' Equity	1,102	1,120	972.18	580.87	301.27	432.96
Total Liabilities & Equity	1,223	1,280	1,402	1,429	1,524	1,611

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	25.18	-	331.75	689.54	951.78	974.43
Net Cash (Debt)	403.34	618.72	412.1	30.94	-194.16	-153.31
Net Cash Growth	-34.72%	50.14%	1232.00%	-	-	-
Net Cash Per Share	0.54	0.84	0.60	0.05	-0.37	-0.29
Filing Date Shares Outstanding	742.32	745.67	728.59	609.17	536.69	536.62
Total Common Shares Outstanding	742.32	745.67	728.59	609.17	536.69	536.62
Working Capital	676.29	746.04	538.72	793.38	782.46	781.7
Book Value Per Share	1.46	1.50	1.25	0.72	0.18	0.81
Tangible Book Value	1,016	1,076	917.99	521.67	244.04	381.39
Tangible Book Value Per Share	1.37	1.44	1.17	0.63	0.07	0.71
Buildings	-	371.25	429.39	427.32	413.92	426.8
Machinery	-	179.36	224.35	221.97	220.86	221.01
Construction In Progress	-	0.02	0.03	0.03	-	0.9

Data Source: S&P Global Market Intelligence Last updated: Oct 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error